JPS6257632B2 - - Google Patents
Info
- Publication number
- JPS6257632B2 JPS6257632B2 JP53016659A JP1665978A JPS6257632B2 JP S6257632 B2 JPS6257632 B2 JP S6257632B2 JP 53016659 A JP53016659 A JP 53016659A JP 1665978 A JP1665978 A JP 1665978A JP S6257632 B2 JPS6257632 B2 JP S6257632B2
- Authority
- JP
- Japan
- Prior art keywords
- cis
- dimethyl
- piperidinyl
- propyl
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims description 33
- 239000000203 mixture Substances 0.000 claims description 30
- 239000002253 acid Substances 0.000 claims description 15
- 150000003839 salts Chemical class 0.000 claims description 14
- APUDBKTWDCXQJA-QIDMFYOTSA-N pirmenol Chemical compound C[C@H]1CCC[C@@H](C)N1CCCC(O)(C=1N=CC=CC=1)C1=CC=CC=C1 APUDBKTWDCXQJA-QIDMFYOTSA-N 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 4
- GCSHUYKULREZSJ-UHFFFAOYSA-N phenyl(pyridin-2-yl)methanone Chemical compound C=1C=CC=NC=1C(=O)C1=CC=CC=C1 GCSHUYKULREZSJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000003416 antiarrhythmic agent Substances 0.000 claims description 3
- 230000003288 anthiarrhythmic effect Effects 0.000 claims description 2
- JDOZOOBCADNBIJ-UHFFFAOYSA-N lithium;2h-pyridin-2-ide Chemical compound [Li+].C1=CC=N[C-]=C1 JDOZOOBCADNBIJ-UHFFFAOYSA-N 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000003386 piperidinyl group Chemical group 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 31
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 22
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 239000000243 solution Substances 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 11
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 11
- -1 piperidine compound Chemical class 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 239000002775 capsule Substances 0.000 description 6
- 239000012458 free base Substances 0.000 description 6
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 6
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 6
- 239000000284 extract Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- CRDBTWHALLRFOX-AOOOYVTPSA-N 3-[(2r,6s)-2,6-dimethylpiperidin-1-yl]propan-1-ol Chemical compound C[C@H]1CCC[C@@H](C)N1CCCO CRDBTWHALLRFOX-AOOOYVTPSA-N 0.000 description 4
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 4
- 239000005977 Ethylene Substances 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000000543 intermediate Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- LOUPRKONTZGTKE-LHHVKLHASA-N quinidine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@H]2[C@@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-LHHVKLHASA-N 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- SDGKUVSVPIIUCF-KNVOCYPGSA-N (2r,6s)-2,6-dimethylpiperidine Chemical compound C[C@H]1CCC[C@@H](C)N1 SDGKUVSVPIIUCF-KNVOCYPGSA-N 0.000 description 3
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 229910052744 lithium Inorganic materials 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- LBUPWCHXRSTTNO-UHFFFAOYSA-N 2,2-dimethylpiperidine Chemical compound CC1(C)CCCCN1 LBUPWCHXRSTTNO-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- FFSAXUULYPJSKH-UHFFFAOYSA-N butyrophenone Chemical compound CCCC(=O)C1=CC=CC=C1 FFSAXUULYPJSKH-UHFFFAOYSA-N 0.000 description 2
- 239000007958 cherry flavor Substances 0.000 description 2
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 229940099112 cornstarch Drugs 0.000 description 2
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 150000004677 hydrates Chemical class 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 229960004194 lidocaine Drugs 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 150000004682 monohydrates Chemical class 0.000 description 2
- XTEGVFVZDVNBPF-UHFFFAOYSA-N naphthalene-1,5-disulfonic acid Chemical compound C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1S(O)(=O)=O XTEGVFVZDVNBPF-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 229960001404 quinidine Drugs 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 235000009518 sodium iodide Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- VOGQZKPKCZDFBF-AOOOYVTPSA-N (2r,6s)-1-(3-chloropropyl)-2,6-dimethylpiperidine Chemical compound C[C@H]1CCC[C@@H](C)N1CCCCl VOGQZKPKCZDFBF-AOOOYVTPSA-N 0.000 description 1
- PEDXCVQZZVVOGO-UKMDXRBESA-N (2r,6s)-2,6-dimethylpiperidine;hydrochloride Chemical compound Cl.C[C@H]1CCC[C@@H](C)N1 PEDXCVQZZVVOGO-UKMDXRBESA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- CEEKMXMGOHQJAL-UHFFFAOYSA-N 1-(3-chloropropyl)-2,6-dimethylpiperidine;hydrochloride Chemical compound Cl.CC1CCCC(C)N1CCCCl CEEKMXMGOHQJAL-UHFFFAOYSA-N 0.000 description 1
- 229940078693 1-myristylpicolinium Drugs 0.000 description 1
- IMRWILPUOVGIMU-UHFFFAOYSA-N 2-bromopyridine Chemical compound BrC1=CC=CC=N1 IMRWILPUOVGIMU-UHFFFAOYSA-N 0.000 description 1
- RQFUZUMFPRMVDX-UHFFFAOYSA-N 3-Bromo-1-propanol Chemical compound OCCCBr RQFUZUMFPRMVDX-UHFFFAOYSA-N 0.000 description 1
- GHEFQKHLHFXSBR-UHFFFAOYSA-N 4-chloro-1-phenylbutan-1-one Chemical compound ClCCCC(=O)C1=CC=CC=C1 GHEFQKHLHFXSBR-UHFFFAOYSA-N 0.000 description 1
- ZCTSINFCZHUVLI-UHFFFAOYSA-M 4-methyl-1-tetradecylpyridin-1-ium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCC[N+]1=CC=C(C)C=C1 ZCTSINFCZHUVLI-UHFFFAOYSA-M 0.000 description 1
- YRISKTNAYHHICR-UHFFFAOYSA-N 4-piperidin-1-ylbutan-1-ol Chemical class OCCCCN1CCCCC1 YRISKTNAYHHICR-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 206010047289 Ventricular extrasystoles Diseases 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000011260 aqueous acid Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- BFAKENXZKHGIGE-UHFFFAOYSA-N bis(2,3,5,6-tetrafluoro-4-iodophenyl)diazene Chemical compound FC1=C(C(=C(C(=C1F)I)F)F)N=NC1=C(C(=C(C(=C1F)F)I)F)F BFAKENXZKHGIGE-UHFFFAOYSA-N 0.000 description 1
- 235000012206 bottled water Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 239000007963 capsule composition Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000007887 hard shell capsule Substances 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 239000003701 inert diluent Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000002642 intravenous therapy Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 1
- 150000002641 lithium Chemical class 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000007968 orange flavor Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- WLJNZVDCPSBLRP-UHFFFAOYSA-N pamoic acid Chemical compound C1=CC=C2C(CC=3C4=CC=CC=C4C=C(C=3O)C(=O)O)=C(O)C(C(O)=O)=CC2=C1 WLJNZVDCPSBLRP-UHFFFAOYSA-N 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- PDTFCHSETJBPTR-UHFFFAOYSA-N phenylmercuric nitrate Chemical compound [O-][N+](=O)O[Hg]C1=CC=CC=C1 PDTFCHSETJBPTR-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 229940116317 potato starch Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- SHNUBALDGXWUJI-UHFFFAOYSA-N pyridin-2-ylmethanol Chemical compound OCC1=CC=CC=N1 SHNUBALDGXWUJI-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- XWGJFPHUCFXLBL-UHFFFAOYSA-M rongalite Chemical compound [Na+].OCS([O-])=O XWGJFPHUCFXLBL-UHFFFAOYSA-M 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 1
- 229910001948 sodium oxide Inorganic materials 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- NQRYJNQNLNOLGT-UHFFFAOYSA-N tetrahydropyridine hydrochloride Natural products C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
- 229940033663 thimerosal Drugs 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 235000012431 wafers Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/16—Radicals substituted by halogen atoms or nitro radicals
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Description
æ¬çºæã¯æ°èŠã®ïŒâãããªãžã³ãã¿ããŒã«åå
ç©ããã³ãããã®è£œé æ³ã«é¢ãããæŽã«è©³ãã
ã¯ãæ¬çºæã¯åŒ ãæããïŒïŒãâïŒâã·ã¹âαâãïŒâïŒïŒã»ïŒâãž
ã¡ãã«âïŒâãããªãžãã«ïŒãããã«ãâαâã
ãšãã«âïŒâããªãžã³ã¡ã¿ããŒã«ããã®é žä»å
å¡©ãåèšååç©ã®è£œé æ¹æ³ãåèšååç©ãå«æã
ãå¿èäžæŽèã®æ²»ççšå»è¬çµæç©ã«é¢ããã æ¬çºæã«ããã°ãåèšååç©ã¯ãåŒ ã®ååç©ãã·ã¹é äœãæããåŒ ã®ååç©ãšåå¿ãããããšã«ãã€ãŠè£œé ããããš
ãã§ããã ãã®åå¿ã¯ãäžè¬ã«æº¶åªäŸãã°ãšãŒãã«ïŒãžãš
ãã«ãšãŒãã«ãããã©ããããã©ã³ããžãšãã¬ã³
ã°ãªã³ãŒã«ãžã¡ãã«ãšãŒãã«ãã®ä»ïŒãçåæ°ŽçŽ
ïŒãã³ãŒã³ããã«ãšã³ããããµã³ãããã¿ã³ãã®
ä»ïŒãŸãã¯ãããã®æ··åç©äžã§â80âãïŒ10âã«
ãããŠïŒã12æéã奜ãŸããã¯â60ãâ80âã§ïŒ
ãïŒæéããããŠæ¬¡ãã§âïŒâãïŒïŒâã§ïŒãïŒ
æéã®éå®æœãããã奜ãŸãã溶åªç³»ã¯å Žåã«ã
ãããã¿ã³ãšæ··åããããã©ããããã©ã³ã䜿çš
ããã ãããªãžã³ååç©ïŒïŒïŒã¢ã«ã«å¯ŸããŠå°ããš
ãïŒã¢ã«ã®ããªãžã«ãªããŠã ïŒïŒã䜿çšãã¹ã
ã§ããããéå°ã®å©ãªããŠã ååç©ã奜ãŸããã åŒã®ååç©ã®äžéäœããéå±èªå°äœããé žæ§
ïŒåžæ°Žæ§å¡©åæ°ŽçŽ é žãæ°Žæ§å¡©åã¢ã³ã¢ããŠã ãåž
æ°Žæ§ç¡«é žãã®ä»ïŒãäžæ§ãŸãã¯å¡©åºæ§ïŒåžæ°Žæ§æ°Ž
é žåãããªãŠã ãåžæ°Žæ§æ°Žé žåã«ãªãŠã ãã®ä»ïŒ
ã®æ¡ä»¶äžã奜ãŸããã¯äžæ§æ¡ä»¶äžã«å æ°Žå解ã
ãã ãã®çæç©ã¯ãã®PHãé©åœã®èª¿æŽããããšã«ã
ã€ãŠéé¢å¡©åºãšããŠãããŸãã¯ãã®é žä»å å¡©ãšã
ãŠåé¢ããããšãã§ããã ã·ã¹âγâïŒïŒã»ïŒâãžã¡ãã«ãããªãžãïŒã
ããããšãã³ã¯ãéå°ã®ã·ã¹âïŒã»ïŒâãžã¡ãã«
ãããªãžã³ãγâã¯ãããããããšãã³ãšãã¬ã³
ã±ã¿ãŒã«ãšæ²åãããªãŠã ã®ååšäžã«çŽ48æéé
æµããã次ãã§åŸãããã¢ããã±ã¿ããŒã«ãæ°Žæ§
å¡©åæ°ŽçŽ é žã§å æ°Žå解ãããããŠæ¬¡ãã§æ°Žæ§æ°Žé ž
åãããªãŠã ã§å¡©åºæ§ãšããããšã«ãã€ãŠè£œé ã
ããã γâã¯ãããããããšãã³ãšãã¬ã³ã±ã¿ãŒã«
ã¯ã觊åªãšããŠïœâãã«ãšã³ã¹ã«ãã³é žã䜿çšã
ãŠÎ³âã¯ãããããããšãã³ããšãã¬ã³ã°ãªã³ãŒ
ã«ãšåå¿ãããããšã«ãã補é ãããããã®åå¿
ã¯ã溶åªãšããŠã®ãã³ãŒã³ãããŠåå¿ç³»ã«çµåã
ããæ°Žãã©ããã䜿çšããŠå®æœãããããã®åå¿
æ··åç©ãææéã®æ°ŽãéãããããŸã§éæµãã次
ãã§é žãäžåãããããŠæº¶åªãé€å»ããã ãŸããæ¬çºæã«ããã°ãæ¬çºæã®ååç©ã¯ãã·
ã¹é äœãæããåŒ ã®ååç©ãïŒâãã³ãŸã€ã«ããªãžã³ãšé©åœãªæº¶åª
äŸãã°ãšãŒãã«ïŒãžãšãã«ãšãŒãã«ãããã©ãã
ããã©ã³ããžãšãã¬ã³ã°ãªã³ãŒã«ãžã¡ãã«ãšãŒã
ã«ãã®ä»ïŒã®äžã§ïŒã24æéïŒâã60âã§åå¿ã
ããããšã«ãã€ãŠè£œé ããããšãã§ããã奜ãŸã
ãåå¿æ¡ä»¶ã¯æº¶åªãšããŠããã©ããããã©ã³ãã
ããŠ20âã35âã®æž©åºŠç¯å²ã§12æéã18æéã®å
å¿æéã䜿çšããã 倧çŽåœéã®æ§é åŒã®ãªããŠã èªå°äœããã³ïŒ
âãã³ãŸã€ã«ããªãžã³ã䜿çšããããšã奜ãŸã
ãã åŒã®ååç©ã®äžéäœéå±èªå°äœããé žæ§ïŒåž
æ°Žæ§å¡©åæ°ŽçŽ é žãæ°Žæ§å¡©åã¢ã³ã¢ããŠã ãåžæ°Žæ§
ç¡«é žãã®ä»ïŒãäžæ§ãŸãã¯å¡©åºæ§ïŒåžæ°Žæ§æ°Žé žå
ãããªãŠã ãåžæ°Žæ§æ°Žé žåã«ãªãŠã ãã®ä»ïŒã®æ¡
件äžã奜ãŸããã¯äžæ§æ¡ä»¶äžã«å æ°Žå解ããã ãããçæç©ã¯ããã®PHãé©åœã«èª¿æŽããããš
ã«ãã€ãŠéé¢å¡©åºãŸãã¯ãã®é žä»å å¡©ãšããŠåé¢
ããããšãã§ããã ããã©ããããã©ã³äžã§ãïŒæé以äžã®éãïŒ
åœéã®ã·ã¹âïŒâïŒïŒâã¯ãããããã«ïŒâïŒã»ïŒ
âãžã¡ãã«ãããªãžã³ãïŒåœéã®ãªããŠã ãšåå¿
ãããããšã«ãã€ãŠãã·ã¹âïŒâïŒïŒâãªããªã
ããã«ïŒâïŒã»ïŒâãžã¡ãã«ãããªãžã³ã補é ã
ãããéåŸãæ®å溶液ãçŽæ¥ãã³ãŸããšãã³ãš
åå¿ãããã ãã³ãŒã³äžã§ããªãã«ã¯ããªããã·ã¹âïŒã»ïŒ
âãžã¡ãã«âïŒâãããªãžã³ãããããŒã«ãšïŒâ
ãïŒâã®æž©åºŠã§30åéåå¿ãã次ãã§ïŒæééæµ
ãããããšã«ãã€ãŠãã·ã¹âïŒâïŒïŒâã¯ããã
ããã«ïŒâïŒã»ïŒâãžã¡ãã«ãããªãžã³ã補é ã
ããããã®å¡©çŽ åçæç©ã¯éã«ãã€ãŠå¡©é žå¡©ãš
ããŠåé¢ãããã çŽïŒæéã®ééæµãã·ã¬ã³äžã§ïŒâããã¢ãã
ãããŒã«ãéå°ã®ã·ã¹âïŒã»ïŒâãžã¡ãã«ãããª
ãžã³ãšåå¿ãããããšã«ãã€ãŠãã·ã¹âïŒã»ïŒâ
ãžã¡ãã«âïŒâãããªãžã³ãããããŒã«ã補é ã
ããããã®ã·ã¹âïŒã»ïŒâãžã¡ãã«âïŒâãããª
ãžã³ãããããŒã«ã¯èžæºã«ãã€ãŠåé¢ãããã åŒã®éé¢å¡©åºã¯çš®ã ã®ç¡æ©ããã³ææ©é žã®ã
ããããšå ±ã«ãæ¬çºæã®äžéšã§ããé žä»å å¡©ã圢
æãããå žåçãªé žä»å å¡©ã¯ãå¡©é žãèåæ°ŽçŽ
é žãç¡«é žãã¹ã«ãã¢ãã³é žãç¡é žãçé žãé ¢é žã
ã¯ãšã³é žãé ç³é žãã³ãã¯é žãèé žãå®æ¯éŠé žã
ãã¬ã€ã³é žããªã³ãŽé žãä¹³é žãã°ã«ã³ã³é žããã
ã¿ã¬ã³âïŒã»ïŒâãžã¹ã«ãã³é žãã¡ã¿ã³ã¹ã«ãã³
é žãïœâãã«ãšã³ã¹ã«ãã³é žãããã³ãã¢ã³é ž
ïŒPamoic acidïŒã®æ§ãªé žã§åœ¢æããããéé¢å¡©
åºããã³ãããã®å¡©ã¯ãPHã®èª¿æŽã«ãã€ãŠçžäºã«
å€æå¯èœã§ããããããã¯æº¶è§£æ§ãç°ãªãããã©
ãããã以å€ã§ã¯æ¬çºæã®ç®çã«å¯ŸããŠã¯ç䟡ã§
ããã æ¬çºæã®ååç©ã¯ç¡æ°Žã®åœ¢æ ããªãã³ã«æ°Žåç©
ãå«ã溶åªåããã圢æ ã§ååšããããäžé žã«ã
æ°Žåç©ããã³è¬ç©åŠçã«èš±å®¹ããã溶åªãšã®æº¶åª
åç©ã¯ãæ¬çºæã®ç®çã«å¯ŸããŠã¯ãç¡æ°Žç©ããªã
ã¡é溶åªå圢æ ã®ãã®ãšç䟡ã§ãããæ¬çºæã®å
åç©ã¯ãŸããæšæºçåé¢æè¡ã«ãã€ãŠïŒ²ããã³ïŒ³
ç°æ§äœãšããŠãåŸãããšãã§ããã æ¬çºæã®ååç©ã¯è¬çäœçšå€ãšããŠäŸ¡å€ããæ°
èŠãªååç©ã§ãããæŽã«è©³ããã¯ããããååç©
ã¯æäžæŽèå€ã§ããããããååç©ã®æŽ»æ§ã¯ã次
ã®ææŽæèã¹ã¯ãªãŒãã³ã°è©Šéšã«ãã€ãŠç€ºãã
ãã ãCirculationã第ïŒå·»ç¬¬1318é ïŒ1950ïŒã«å ±
åãããŠããæ¹æ³ã«åŸã€ãŠç¬ãæè¡ãããïŒïŒã
âïŒâã·ã¹âαâãïŒâïŒïŒã»ïŒâãžã¡ãã«âïŒâ
ãããªãžãã«ïŒãããã«ãâαâããšãã«âïŒâ
ããªãžã³ã¡ã¿ããŒã«ããªãã«ã€ã³ããã³ãããžã³
ãå åèçµçŽ®ã®19ã24æéåŸã«éèå çã«è©Šéšã
ããååç©ã®æå¹åºŠã¯ãå¿å®€ç°ææ§æ¶åãæŽæ¶å
ã«å€æãããçšåºŠã«ãã€ãŠæž¬å®ãããã 次ã«ç€ºããè¡šã¯ïŒïŒãâïŒâã·ã¹âαâãïŒâ
ïŒïŒã»ïŒâãžã¡ãã«âïŒâãããªãžãã«ïŒããã
ã«ãâαâããšãã«âïŒâããªãžã³ã¡ã¿ããŒã«ã
ãã³æ¢ç¥ã®æäžæŽèå€ã§ãããªãã«ã€ã³ããã³ã
ããžã³ã«é¢ããŠå®æœãããã¹ã¯ãªãŒãã³ã°ã®çµæ
ãäžããŠããã
ç©ããã³ãããã®è£œé æ³ã«é¢ãããæŽã«è©³ãã
ã¯ãæ¬çºæã¯åŒ ãæããïŒïŒãâïŒâã·ã¹âαâãïŒâïŒïŒã»ïŒâãž
ã¡ãã«âïŒâãããªãžãã«ïŒãããã«ãâαâã
ãšãã«âïŒâããªãžã³ã¡ã¿ããŒã«ããã®é žä»å
å¡©ãåèšååç©ã®è£œé æ¹æ³ãåèšååç©ãå«æã
ãå¿èäžæŽèã®æ²»ççšå»è¬çµæç©ã«é¢ããã æ¬çºæã«ããã°ãåèšååç©ã¯ãåŒ ã®ååç©ãã·ã¹é äœãæããåŒ ã®ååç©ãšåå¿ãããããšã«ãã€ãŠè£œé ããããš
ãã§ããã ãã®åå¿ã¯ãäžè¬ã«æº¶åªäŸãã°ãšãŒãã«ïŒãžãš
ãã«ãšãŒãã«ãããã©ããããã©ã³ããžãšãã¬ã³
ã°ãªã³ãŒã«ãžã¡ãã«ãšãŒãã«ãã®ä»ïŒãçåæ°ŽçŽ
ïŒãã³ãŒã³ããã«ãšã³ããããµã³ãããã¿ã³ãã®
ä»ïŒãŸãã¯ãããã®æ··åç©äžã§â80âãïŒ10âã«
ãããŠïŒã12æéã奜ãŸããã¯â60ãâ80âã§ïŒ
ãïŒæéããããŠæ¬¡ãã§âïŒâãïŒïŒâã§ïŒãïŒ
æéã®éå®æœãããã奜ãŸãã溶åªç³»ã¯å Žåã«ã
ãããã¿ã³ãšæ··åããããã©ããããã©ã³ã䜿çš
ããã ãããªãžã³ååç©ïŒïŒïŒã¢ã«ã«å¯ŸããŠå°ããš
ãïŒã¢ã«ã®ããªãžã«ãªããŠã ïŒïŒã䜿çšãã¹ã
ã§ããããéå°ã®å©ãªããŠã ååç©ã奜ãŸããã åŒã®ååç©ã®äžéäœããéå±èªå°äœããé žæ§
ïŒåžæ°Žæ§å¡©åæ°ŽçŽ é žãæ°Žæ§å¡©åã¢ã³ã¢ããŠã ãåž
æ°Žæ§ç¡«é žãã®ä»ïŒãäžæ§ãŸãã¯å¡©åºæ§ïŒåžæ°Žæ§æ°Ž
é žåãããªãŠã ãåžæ°Žæ§æ°Žé žåã«ãªãŠã ãã®ä»ïŒ
ã®æ¡ä»¶äžã奜ãŸããã¯äžæ§æ¡ä»¶äžã«å æ°Žå解ã
ãã ãã®çæç©ã¯ãã®PHãé©åœã®èª¿æŽããããšã«ã
ã€ãŠéé¢å¡©åºãšããŠãããŸãã¯ãã®é žä»å å¡©ãšã
ãŠåé¢ããããšãã§ããã ã·ã¹âγâïŒïŒã»ïŒâãžã¡ãã«ãããªãžãïŒã
ããããšãã³ã¯ãéå°ã®ã·ã¹âïŒã»ïŒâãžã¡ãã«
ãããªãžã³ãγâã¯ãããããããšãã³ãšãã¬ã³
ã±ã¿ãŒã«ãšæ²åãããªãŠã ã®ååšäžã«çŽ48æéé
æµããã次ãã§åŸãããã¢ããã±ã¿ããŒã«ãæ°Žæ§
å¡©åæ°ŽçŽ é žã§å æ°Žå解ãããããŠæ¬¡ãã§æ°Žæ§æ°Žé ž
åãããªãŠã ã§å¡©åºæ§ãšããããšã«ãã€ãŠè£œé ã
ããã γâã¯ãããããããšãã³ãšãã¬ã³ã±ã¿ãŒã«
ã¯ã觊åªãšããŠïœâãã«ãšã³ã¹ã«ãã³é žã䜿çšã
ãŠÎ³âã¯ãããããããšãã³ããšãã¬ã³ã°ãªã³ãŒ
ã«ãšåå¿ãããããšã«ãã補é ãããããã®åå¿
ã¯ã溶åªãšããŠã®ãã³ãŒã³ãããŠåå¿ç³»ã«çµåã
ããæ°Žãã©ããã䜿çšããŠå®æœãããããã®åå¿
æ··åç©ãææéã®æ°ŽãéãããããŸã§éæµãã次
ãã§é žãäžåãããããŠæº¶åªãé€å»ããã ãŸããæ¬çºæã«ããã°ãæ¬çºæã®ååç©ã¯ãã·
ã¹é äœãæããåŒ ã®ååç©ãïŒâãã³ãŸã€ã«ããªãžã³ãšé©åœãªæº¶åª
äŸãã°ãšãŒãã«ïŒãžãšãã«ãšãŒãã«ãããã©ãã
ããã©ã³ããžãšãã¬ã³ã°ãªã³ãŒã«ãžã¡ãã«ãšãŒã
ã«ãã®ä»ïŒã®äžã§ïŒã24æéïŒâã60âã§åå¿ã
ããããšã«ãã€ãŠè£œé ããããšãã§ããã奜ãŸã
ãåå¿æ¡ä»¶ã¯æº¶åªãšããŠããã©ããããã©ã³ãã
ããŠ20âã35âã®æž©åºŠç¯å²ã§12æéã18æéã®å
å¿æéã䜿çšããã 倧çŽåœéã®æ§é åŒã®ãªããŠã èªå°äœããã³ïŒ
âãã³ãŸã€ã«ããªãžã³ã䜿çšããããšã奜ãŸã
ãã åŒã®ååç©ã®äžéäœéå±èªå°äœããé žæ§ïŒåž
æ°Žæ§å¡©åæ°ŽçŽ é žãæ°Žæ§å¡©åã¢ã³ã¢ããŠã ãåžæ°Žæ§
ç¡«é žãã®ä»ïŒãäžæ§ãŸãã¯å¡©åºæ§ïŒåžæ°Žæ§æ°Žé žå
ãããªãŠã ãåžæ°Žæ§æ°Žé žåã«ãªãŠã ãã®ä»ïŒã®æ¡
件äžã奜ãŸããã¯äžæ§æ¡ä»¶äžã«å æ°Žå解ããã ãããçæç©ã¯ããã®PHãé©åœã«èª¿æŽããããš
ã«ãã€ãŠéé¢å¡©åºãŸãã¯ãã®é žä»å å¡©ãšããŠåé¢
ããããšãã§ããã ããã©ããããã©ã³äžã§ãïŒæé以äžã®éãïŒ
åœéã®ã·ã¹âïŒâïŒïŒâã¯ãããããã«ïŒâïŒã»ïŒ
âãžã¡ãã«ãããªãžã³ãïŒåœéã®ãªããŠã ãšåå¿
ãããããšã«ãã€ãŠãã·ã¹âïŒâïŒïŒâãªããªã
ããã«ïŒâïŒã»ïŒâãžã¡ãã«ãããªãžã³ã補é ã
ãããéåŸãæ®å溶液ãçŽæ¥ãã³ãŸããšãã³ãš
åå¿ãããã ãã³ãŒã³äžã§ããªãã«ã¯ããªããã·ã¹âïŒã»ïŒ
âãžã¡ãã«âïŒâãããªãžã³ãããããŒã«ãšïŒâ
ãïŒâã®æž©åºŠã§30åéåå¿ãã次ãã§ïŒæééæµ
ãããããšã«ãã€ãŠãã·ã¹âïŒâïŒïŒâã¯ããã
ããã«ïŒâïŒã»ïŒâãžã¡ãã«ãããªãžã³ã補é ã
ããããã®å¡©çŽ åçæç©ã¯éã«ãã€ãŠå¡©é žå¡©ãš
ããŠåé¢ãããã çŽïŒæéã®ééæµãã·ã¬ã³äžã§ïŒâããã¢ãã
ãããŒã«ãéå°ã®ã·ã¹âïŒã»ïŒâãžã¡ãã«ãããª
ãžã³ãšåå¿ãããããšã«ãã€ãŠãã·ã¹âïŒã»ïŒâ
ãžã¡ãã«âïŒâãããªãžã³ãããããŒã«ã補é ã
ããããã®ã·ã¹âïŒã»ïŒâãžã¡ãã«âïŒâãããª
ãžã³ãããããŒã«ã¯èžæºã«ãã€ãŠåé¢ãããã åŒã®éé¢å¡©åºã¯çš®ã ã®ç¡æ©ããã³ææ©é žã®ã
ããããšå ±ã«ãæ¬çºæã®äžéšã§ããé žä»å å¡©ã圢
æãããå žåçãªé žä»å å¡©ã¯ãå¡©é žãèåæ°ŽçŽ
é žãç¡«é žãã¹ã«ãã¢ãã³é žãç¡é žãçé žãé ¢é žã
ã¯ãšã³é žãé ç³é žãã³ãã¯é žãèé žãå®æ¯éŠé žã
ãã¬ã€ã³é žããªã³ãŽé žãä¹³é žãã°ã«ã³ã³é žããã
ã¿ã¬ã³âïŒã»ïŒâãžã¹ã«ãã³é žãã¡ã¿ã³ã¹ã«ãã³
é žãïœâãã«ãšã³ã¹ã«ãã³é žãããã³ãã¢ã³é ž
ïŒPamoic acidïŒã®æ§ãªé žã§åœ¢æããããéé¢å¡©
åºããã³ãããã®å¡©ã¯ãPHã®èª¿æŽã«ãã€ãŠçžäºã«
å€æå¯èœã§ããããããã¯æº¶è§£æ§ãç°ãªãããã©
ãããã以å€ã§ã¯æ¬çºæã®ç®çã«å¯ŸããŠã¯ç䟡ã§
ããã æ¬çºæã®ååç©ã¯ç¡æ°Žã®åœ¢æ ããªãã³ã«æ°Žåç©
ãå«ã溶åªåããã圢æ ã§ååšããããäžé žã«ã
æ°Žåç©ããã³è¬ç©åŠçã«èš±å®¹ããã溶åªãšã®æº¶åª
åç©ã¯ãæ¬çºæã®ç®çã«å¯ŸããŠã¯ãç¡æ°Žç©ããªã
ã¡é溶åªå圢æ ã®ãã®ãšç䟡ã§ãããæ¬çºæã®å
åç©ã¯ãŸããæšæºçåé¢æè¡ã«ãã€ãŠïŒ²ããã³ïŒ³
ç°æ§äœãšããŠãåŸãããšãã§ããã æ¬çºæã®ååç©ã¯è¬çäœçšå€ãšããŠäŸ¡å€ããæ°
èŠãªååç©ã§ãããæŽã«è©³ããã¯ããããååç©
ã¯æäžæŽèå€ã§ããããããååç©ã®æŽ»æ§ã¯ã次
ã®ææŽæèã¹ã¯ãªãŒãã³ã°è©Šéšã«ãã€ãŠç€ºãã
ãã ãCirculationã第ïŒå·»ç¬¬1318é ïŒ1950ïŒã«å ±
åãããŠããæ¹æ³ã«åŸã€ãŠç¬ãæè¡ãããïŒïŒã
âïŒâã·ã¹âαâãïŒâïŒïŒã»ïŒâãžã¡ãã«âïŒâ
ãããªãžãã«ïŒãããã«ãâαâããšãã«âïŒâ
ããªãžã³ã¡ã¿ããŒã«ããªãã«ã€ã³ããã³ãããžã³
ãå åèçµçŽ®ã®19ã24æéåŸã«éèå çã«è©Šéšã
ããååç©ã®æå¹åºŠã¯ãå¿å®€ç°ææ§æ¶åãæŽæ¶å
ã«å€æãããçšåºŠã«ãã€ãŠæž¬å®ãããã 次ã«ç€ºããè¡šã¯ïŒïŒãâïŒâã·ã¹âαâãïŒâ
ïŒïŒã»ïŒâãžã¡ãã«âïŒâãããªãžãã«ïŒããã
ã«ãâαâããšãã«âïŒâããªãžã³ã¡ã¿ããŒã«ã
ãã³æ¢ç¥ã®æäžæŽèå€ã§ãããªãã«ã€ã³ããã³ã
ããžã³ã«é¢ããŠå®æœãããã¹ã¯ãªãŒãã³ã°ã®çµæ
ãäžããŠããã
ãè¡šã
æ¬çºæã«ããååç©ã«ã€ããŠãã¹ã€ã¹
ïŒSwissïŒCF1ç³»ããŠã¹ïŒäœé21ã29ïœãçŽïŒé±
什ïŒã®éããã³éãçšããŠãã®æ¥æ§æ¯æ§ã調ã¹ã
çµæã¯ä»¥äžã®ãšããã§ãã€ããè©Šéšã«çšãããã
ã®ã¯æ¬çºæã«ããååç©ã®å¡©é žå¡©ã§ããã é é LD50ïŒmgïŒKgïŒïŒéèå æäžïŒ 24.07 24.42 æŽã«ãæ¬çºæã¯ïŒïŒãâïŒâã·ã¹âαâãïŒâ
ïŒïŒã»ïŒâãžã¡ãã«âïŒâãããªãžãã«ïŒããã
ã«ãâαâããšãã«âïŒâããªãžã³ã¡ã¿ããŒã«ã
ãã³ãã®è¬ç©åŠçã«èš±å®¹ãããé žä»å å¡©ãå å«ã
ãå»è¬çµæç©ã«ãé¢ãããè¬ç©åŠçã«èš±å®¹ããã
é žä»å 塩圢æ ã®ãã®ã®ããã€ãã®å žåäŸã¯ãå¡©é ž
å¡©ãç¡«é žå¡©ãçé žå¡©ãã¯ãšã³é žå¡©ããã¢ã³é žå¡©ã
é ¢é žå¡©ããã³ãã¬ã€ã³é žå¡©ã§ããã æŽã«è©³ããã¯ãïŒïŒãâïŒâã·ã¹âαâãïŒâ
ïŒïŒã»ïŒâãžã¡ãã«âïŒâãããªãžãã«ïŒããã
ã«ãâαâããšãã«âïŒâããªãžã³ã¡ã¿ããŒã«ã
ãã³ãã®è¬ç©åŠçã«èš±å®¹ãããé žä»å å¡©ã¯ãïŒæ¥
äœéïŒKgåœãçŽ0.1mgãçŽ10mgã®ç¯å²ã®éã§æäž
ããå Žåãåºä¹³é¡äŸãã°ç«ãç¬ã銬ã人ãã®ä»ã®
å¿èäžæŽèã®å¶åŸ¡ã«é«åºŠã«æçšã§ããããããŠã
ã®ãããªè¬éåäœã䜿çšããã°äœéçŽ70Kgã®åäœ
ã«å¯ŸããŠã¯åèšã§çŽïŒmgãçŽ700mgã®æŽ»æ§æåã
24æéã®éã«å¥œãŸããã¯åå²ããŠæäžãããããš
ã«ãªãã奜ãŸããè¬éæäžæ³ã¯ãïŒæ¥åœãäœéïŒ
KgåœãïŒmgãïŒmgç¯å²ã®æŽ»æ§æåã䜿çšãããã
ã®å Žåãå šïŒæ¥éè¬éãïŒåäœã«åå²ãããããŠ
ãããé©åœãªæéééåŸã«æåããã®ã§ããã æ¬çºæã®ååç©ã¯ãä»»æã®äŸ¿å®ãªçµè·¯ã§ãäŸã
ã°çµå£çã«ãè ¹è å çã«ãç®äžã«ãçèå ãŸãã¯
éèå çã«æäžããããšãã§ããã æŸæããå®å®æ§ããã³éçµè žçšã«ææãããé©
å¿æ§ãæããæ¬çºæã®çµæç©ã¯ãããã¯ã«äŸãã°
æ°Žãå€äŸ¡èèªæã¢ã«ã³ãŒã«ãŸãã¯ãããã®æ··åç©
äžã«0.10ïŒ ã10.0ééïŒ ã®æŽ»æ§ååç©ã溶解ãã
ãããšã«ãã€ãŠåŸããããæ°Žã®ä»ã«ãç¹ã«æºè¶³ã
ã¹ããã®ã¯ã°ãªã»ãªã³ããããã¬ã³ã°ãªã³ãŒã«ã
ãã³ããªãšãã¬ã³ã°ãªã³ãŒã«ã§ãããããªãšãã¬
ã³ã°ãªã³ãŒã«ã¯ãæ°Žããã³ææ©æ¶²äœäž¡è ã«å¯æº¶æ§
ã§ãããŠçŽ200ãçŽ1500ã®ååéãæããäžæ®çº
æ§ã®åžžæ ã§æ¶²äœç¶ã®ããªãšãã¬ã³ã°ãªã³ãŒã«ã®æ··
åç©ãããªãã åèšããã¯ã«ã«æº¶è§£ãããããã掻æ§ååç©ã®
éã¯0.10ã20.0ééïŒ ã«å€åããããããã©ãã
䜿çšããã掻æ§ååç©éã¯çŽ1.0ãçŽ10.0ééïŒ
ã§ããããšã奜ãŸãããåèšã®äžæ®çºæ§ããªãšã
ã¬ã³ã°ãªã³ãŒã«ã®çš®ã ã®æ··åç©ã䜿çšããããã
ã©ããçŽ200ãçŽ400ã®å¹³åååéãæããæ··åç©
ã®äœ¿çšã奜ãŸããã åèšååç©ã®ä»ã«ãæ¬çºæã®éçµè žæäžçšæº¶æ¶²
ã«ã¯ããŸã现èããã³ãã³ã®æ±æãé²æ¢ãããã
ã«äœ¿çšãããçš®ã ã®ä¿åå€ãå«æãããããšãã§
ããããã®ãããªç®çã«äœ¿çšãããä¿åå€ã¯ãäŸ
ãã°ãã³ãžã«ã¢ã«ã³ãŒã«ãããªã¹ãã«âγâãã³
ãªããŠã ã¯ããªããããšãã«ç¡é žæ°Žéããã³ã¶ã«
ã³ããŠã ã¯ããªããããšããã«ã¢ã«ã³ãŒã«ãïœâ
ã¯ããããšãã«âαâã°ãªã»ããŒã«ãšãŒãã«ãã¡
ãã«ããã³ãããã©ãã³ããã³ãã¡ããµãŒã«ã§ã
ããå®éåé¡ãšããŠé žåé²æ¢å€ã䜿çšããããšã
䟿å©ã§ãããé©åœãªé žåé²æ¢å€ãšããŠã¯ãäŸãã°
éäºç¡«é žãããªãŠã ãã¡ã¿éäºç¡«é žãããªãŠã ã
ããã³ãããªãŠã ãã«ã ã¢ã«ãããã¹ã«ããã·ã¬
ãŒããããããããäžè¬ã«ã¯ãçŽ0.05ãçŽ0.2ïŒ
æ¿åºŠã®é žåé²æ¢å€ã䜿çšãããã 掻æ§ååç©ã®å¥œãŸããæ¿åºŠã¯ããã®çµæç©ãæ
å³ãããŠããç®çãçè泚å°ã§ããå Žåã«ã¯ãæ
çµçµæç©ã®ïŒã50mgïŒmlã§ããããããã¯é©åœé
ã®æ°ŽãŸãã¯éèå æ²»ççšã«äœ¿çšãããåžé液äŸã
ã°ç匵ã°ã«ã³ãŒã¹ã§åžéããå Žåã«ã¯ãéèå é©
çšã«ãçããé©å¿ãããããã®äœ¿çšã«å¯ŸããŠã¯ã
çŽ0.5ã25mgïŒmlãŸã§äžãã掻æ§ååç©åææ¿åºŠ
ãæºè¶³ãã¹ããã®ã§ããããããã¯ãŸãã飲çšæ°Ž
ã§åžéããå Žåã«ã¯çµå£æäžçšã«ãé©çšãããã æ¬çºæã®æŽ»æ§ååç©ã¯äŸãã°äžæŽ»æ§åžé液ãŸã
ã¯ååå¯èœãªé£çšæ äœã䜿çšããŠçµå£çã«æäžã
ãããšãã§ãããããŸãã¯ãããã¯ç¡¬è³ªãŸãã¯è»
質ãŒã©ãã³ã«ãã»ã«äžã«å°å ¥ããããšãã§ããã
ãŸãã¯ããããå§çž®æ圢ããŠé å€ãšããããšãã§
ããããŸãã¯ããããçŽæ¥é£é€çšé£åãšæ··åãã
ããšãã§ãããçµå£çæ²»ççšæäžã«å¯ŸããŠã¯ãæ¬
çºæã®æŽ»æ§ååç©ã賊圢å€ã«æ··å ¥ãããããŠé
å€ããããŒããã«ãã»ã«ããšãªãã·ã«ãæžæ¿å€ã
ã·ãããããŠãšãŒãã¢ãŒãããŠãŒã€ã³ã°ã¬ã ãã®
ä»ã®åœ¢ã§äœ¿çšããããšãã§ããããã®ãããªçµæ
ç©ããã³è£œå€ã¯å°ããšã0.1ïŒ ã®æŽ»æ§ååç©ãå«
æããŠããã¹ãã§ãããçµæç©ããã³è£œå€äžã®ïŒ
ã¯å¿è«å€åãããããšãã§ãããããŠããã¯äŸ¿å©
ã«ã¯åäœééã®çŽïŒãçŽ75ïŒ ãŸãã¯ãã以äžã§ã
ãããã®ãããªæ²»ççã«æçšãªçµæç©ãŸãã¯è£œå€
äžã®æŽ»æ§ååç©ã®éã¯ãé©åœãªè¬éãåŸãããã
ããªãã®ã§ãããæ¬çºæã®å¥œãŸããçµæç©ãŸãã¯
補å€ã¯ãçµå£è¬éåäœåœ¢æ ãçŽïŒã200mgã®æŽ»æ§
ååç©ãå«æããããã«è£œé ãããã ãã®é å€ããããŒãããã«ãã«ãã»ã«ãã®ä»ã«
ã¯ã次ã®ãã®ããå«æãããããšãã§ãããçµå
å€äŸãã°ãã©ã¬ã«ã³ããŽã ãã¢ã«ã·ã¢ãŽã ãã³ãŒ
ã³ã¹ã¿ãŒããŸãã¯ãŒã©ãã³ã賊圢å€äŸãã°çé žãž
ã«ã«ã·ãŠã ã厩å£å€äŸãã°ã³ãŒã³ã¹ã¿ãŒãã銬éŽ
è¯æŸ±ç²ãã¢ã«ã®ã³é žãã®ä»ãæ»å€äŸãã°ã¹ãã¢ãª
ã³é žãã°ãã·ãŠã ãããã³çå³æäŸãã°èç³ãä¹³
ç³ãŸãã¯ãµãã«ãªã³ãŸãã¯è³éŠå€äŸãã°ãããŒã
ã³ããå¬ç·æ²¹ãŸãã¯ããšãªãŒéŠæã§ãããè¬éå
äœåœ¢æ ãã«ãã»ã«ã®å Žåã«ã¯ãããã¯åèšã®ãã
ãªçš®é¡ã®ç©è³ªã®ä»ã«æ¶²äœæ äœäŸãã°èèªæ²¹ãå«æ
ããããšãã§ãããçš®ã ã®ãã®ä»ã®ç©è³ªãäŸãã°
ã³ãŒãã€ã³ã°ãšããŠååšãããããšãã§ãããã
ããã¯ãè¬éåäœã®ç©çç圢ç¶ããã以å€ã®æ§åŒ
ã§ä¿®æ£ããããã«é å€ããã«ãŸãã¯ã«ãã»ã«ãã·
ãšã©ãã¯ãç ç³ãŸãã¯ããã¹ã§ã³ãŒãã€ã³ã°ãã
ããšãã§ãããã·ããããŸãã¯ãšãªãã·ã«ã«ã¯ã
掻æ§ååç©ãçå³å€ãšããŠã®èç³ãä¿åæãšããŠ
ã®ã¡ãã«ããã³ãããã«ãã©ãã³ãææããã³è³
éŠæäŸãã°ããšãªãŒãŸãã¯ãªã¬ã³ãžéŠæãå«æã
ããããšãã§ãããå¿è«ããã¹ãŠã®è¬éåäœåœ¢æ
ã®è£œé ã«äœ¿çšããããã¹ãŠã®ç©è³ªã¯ãè¬ç©åŠçã«
çŽç²ã§äžã€äœ¿çšãããéã«ãããŠå®è³ªçã«ç¡æ¯æ§
ã§ããã¹ãã§ããã æ¬çºæã次ã®å®æœäŸã«ãã説æããã äŸ ïŒ 200mlã®ããã©ããããã©ã³äžã«ãæ¹æãã€ã€
â78âã§180mlã®ããã¿ã³äžã®1.6Mããã«ãªããŠ
ã 溶液ãå ããããã®æ··åç©ãçªçŽ äžã«æ¹æãã
ãããã®éã«50mlã®ããã©ããããã©ã³äž43ïœã®
ïŒâããã¢ããªãžã³æº¶æ¶²ãåŸåŸã«ãã®æž©åºŠãâ65
â以äžã«ä¿ã¡ã€ã€å ãããïŒæéæ¹æåŸããã®æ··
åç©ã10åéã«ããã€ãŠ70mlã®ããã©ããããã©
ã³äž65ïœã®ã·ã¹âγâïŒïŒã»ïŒâãžã¡ãã«ãããª
ãžãïŒãããããšãã³ã®æº¶æ¶²ã§åŠçãããããŠâ
65ãâ75âã§æŽã«ïŒæéæ¹æããããã®æ··åç©ã
æ¹æããããŠïŒæéã«ããã€ãŠïŒâãŸã§å æž©ãã
ãã次ãã§30mlã®æ°Žã§åŠçãããäžæŸã¿ã®æ©è²å±€
ãæ²æŸ±ããåºäœããåŸçãããããŠæžå§äžã«ãã®
åã®äœç©ã®çŽ1/3ãŸã§èžçºãããããã®æ®æž£ã2.5
ã®å·åžæ°Žæ§é žåãããªãŠã äžã«æ³šããåŸããã
ïŒïŒãâïŒâã·ã¹âαâãïŒâïŒïŒã»ïŒâãžã¡ãã«â
ïŒâãããªãžãã«ïŒãããã«ãâαâããšãã«â
ïŒâããªãžã³ã¡ã¿ããŒã«ã®æ²æŸ±ãéã«ããé€å»
ããæ°ŽæŽããããŠä¹Ÿç¥ããããç³æ²¹ãšãŒãã«ãã
çµæ¶ååŸã®èç¹70ã71âã ãã®çæç©ãæ°Žæ§ã¡ã¿ããŒã«ããåçµæ¶ããã
å Žåäžæ°Žåç©ãåŸããããm.p.101ã102âã ã¢ãå¡©åæ°ŽçŽ é žå¡©ã¯ãïŒâãããããŒã«äžã«ç¡
æ°Žéé¢å¡©åºã溶解ããããããŠïŒâãããããŒã«
äžã®10ïŒ ã®ä¹Ÿç¥å¡©åæ°ŽçŽ æº¶æ¶²ã®åœéãå ãã次ã
ã§ãšãŒãã«ã§åžéããããŠæ²æŸ±ããå¡©ãéãã
ããšã«ãã€ãŠè£œé ããããm.p.171ã172âã äžéäœã®è£œé ã¯æ¬¡ã®ããã«ããŠãªãããã (a) ã·ã¹âγâïŒïŒã»ïŒâãžã¡ãã«ãããªãžãïŒ
ãããããšã㳠γâã¯ãããããããšãã³ãšãã¬ã³ã±ã¿ãŒã«
619ïœãã·ã¹âïŒã»ïŒâãžã¡ãã«ãããªãžã³700
ïœããã³16ïœã®æ²åãããªãŠã ã®æ··åç©ã48æ
éæ¹æãã€ã€éæµå ç±ããããã®æ··åç©ãå·åŽ
ããïŒã®ç¡æ°ŽãšãŒãã«ã§åžéããããŠéã
ãŠã·ã¹âïŒã»ïŒâãžã¡ãã«ãããªãžã³å¡©é žå¡©ã
é€å»ããããã®ãã€ã«ã¿ãŒã±ãŒããïŒã®ãšãŒ
ãã«ã§æŽããããŠæ¶²ããã³æŽæ¶²ãåãããåŸ
ããããšãŒãã«æº¶æ¶²ãïŒåã500mlåºåéã®æ°Ž
ã§æŽãã次ãã§ïŒã®æ°Žäž300mlã®æ¿å¡©é žã®æº¶
液ã§æœåºããããã®é žæœåºæ¶²ã500mlã®ãšãŒã
ã«ã§æŽãã次ãã§70ã80âã«å ç±ãããããŠæ¬¡
ãã§16æéãããŠå®€æž©ãŸã§å·åŽããããåŸãã
ã溶液ã50ïŒ æ°Žæ§æ°Žé žåãããªãŠã ã§å¡©åºæ§ãš
ãããããŠææ©å±€ãåé¢ããããã®æ°Žæ§å±€ã
500mlã®ãšãŒãã«ã§æœåºãããããŠãã®æœåºæ¶²
ãææ©å±€ã«åãããåããæœåºæ¶²ãæ°Žã§æ°åæŽ
ãã也ç¥ããããããŠèžçºãããããã®æ²¹æ§æ®
枣ãæžå§äžã«èžæºããŠã·ã¹âγâïŒïŒã»ïŒâãž
ã¡ãã«ãããªãžãïŒãããããšãã³ïŒb.p.138
ã141âïŒ0.1mmïŒãåŸãã (b) γâã¯ãããããããšãã³ãšãã¬ã³ã±ã¿ãŒã« 500ïœã®Î³âã¯ãããããããšãã³ã225ïœã®
ãšãã¬ã³ã°ãªã³ãŒã«ã10ïœã®ïœâãã«ãšã³ã¹ã«
ãã³é žããã³1.5ã®ãã³ãŒã³ã®æ··åç©ãæ°Žã
åé¢ãã€ã€æ°ŽåéããããŸã§éæµäžã«å ç±ã
ããåŸããã溶液ãå·åŽãã10mlã®ããªãšãã«
ã¢ãã³ã§äžåããããŠæžå§äžã«èžçºããããšã
ã以äžç²Ÿè£œããããšãªãã«äœ¿çšã«é©åœãªÎ³âã¯
ãããããããšãã³ãšãã¬ã³ã±ã¿ãŒã«ãåŸãã
ãããã®ãã®ã®çŽç²ãªç©è³ªã¯100ã118âïŒ0.1
ã0.8mmã§æ²žéš°ããããŠ57ã59âã§æº¶èããã äŸ ïŒ 50mlã®ããã©ããããã©ã³äž18.98ã®ã·ã¹âïŒ
âïŒïŒâã¯ãããããã«ïŒâïŒã»ïŒâãžã¡ãã«ãã
ãªãžã³ã®æº¶æ¶²ãçªçŽ é°å²æ°äžã«1.4ïœã®ãªããŠã
ã¯ã€ã¢ãš50mlã®ããã©ããããã©ã³ãšã®æ¹ææ··å
ç©äžã«ïŒæéãããŠæ»Žå ãããæ·»å å®äºåŸããã®
æ··åç©ãçªçŽ äžã«æŽã«ïŒæéæ¹æããéå°ã®ãªã
ãŠã éå±ãæäœæ¥ã§é€å»ãããããŠ100mlã®ãã
ã©ããããã©ã³äž18.3ïœã®ïŒâãã³ãŸã€ã«ããªãž
ã³ã®æº¶æ¶²ãæ¹æãã€ã€ïŒæéãããŠæ»Žå ãããã
ã®æ··åç©ã16æéæ¹æãã次ãã§ïŒmlã®æ°Žã§åŠç
ããããã®ææ©çžãæ²æŸ±ããåºäœããåŸçããã
ããŠæžå§äžã«ãã®æåã®äœç©ã®çŽ1/4ãŸã§èžçºã
ããããã®æº¶æ¶²ã400mlã®æ°Žäžã«æ³šãããã®æº¶æ¶²
ãé ¢é žã§é žæ§ãšãããããŠãšãŒãã«ã§æŽãããã®
æ°Žæ§é žæº¶æ¶²ãæ°Žæ§æ°Žé žåãããªãŠã ã§å¡©åºæ§ãšã
ãããŠãšãŒãã«ã§æœåºããããšãŒãã«æœåºæ¶²ãæ°Ž
æŽãã也ç¥ããããŠèžçºããããšãïŒïŒãâïŒâã·
ã¹âαâãïŒâïŒïŒã»ïŒâãžã¡ãã«âïŒâãããªãž
ãã«ïŒãããã«ãâαâããšãã«âïŒâããªãžã³
ã¡ã¿ããŒã«ãåŸãããããã®ãã®ã¯æ°Žæ§ã¡ã¿ããŒ
ã«ããçµæ¶ååŸm.p.100ã102âïŒäžæ°Žåç©ïŒã
åŸãããã äžéäœã®è£œé ã¯æ¬¡ã®ãšããã§ããã (a) ã·ã¹âïŒâïŒïŒâã¯ãããããã«ïŒâïŒã»ïŒâ
ãžã¡ãã«ãããªãžã³ 400mlã®ãã³ãŒã³äž171ïœã®ã·ã¹âïŒã»ïŒâãž
ã¡ãã«âïŒâãããªãžã³ãããããŒã«ã®æ¹æ溶
液ãïŒãïŒãã«å·åŽãããããŠããªãã«ã¯ããª
ã143ïœã30åéãããŠæ»Žå ããããã®æ··åç©
ã次ãã§ïŒæéå ç±éæµããå·åŽããããŠïŒ
ã®ãšãŒãã«ã§åžéãããåŸãããã·ã¹âïŒâ
ïŒïŒâã¯ãããããã«ïŒâïŒã»ïŒâãžã¡ãã«ãã
ãªãžã³å¡©é žå¡©ã®æ²æŸ±ãéã«ããéãããïŒâ
ãããããŒã«ãšãŒãã«ããçµæ¶ååŸã®èç¹ã¯
173ã174âã§ãããéé¢å¡©åºã¯å¿ èŠã«å¿ããŠæ
å°éã®æ°Žã«ãã®å¡©é žå¡©ã溶解ãããå·åŽããã
ãŠå°éå°ã®50ïŒ æ°Žæ§æ°Žé žåãããªãŠã ãå ãã
ããšã«ãã補é ããããéé¢ããå¡©åºãçŽã¡ã«
æ°åºåéã®ãã³ãŒã³ã§æœåºããããã®æœåºæ¶²ã
åãã也ç¥ãããããŠèžçºããããšéé¢å¡©åºã§
ããã·ã¹âïŒâïŒïŒâã¯ãããããã«ïŒâïŒã»ïŒ
âãžã¡ãã«ãããªãžã³ãåŸãããã (b) ã·ã¹âïŒã»ïŒâãžã¡ãã«âïŒâãããªãžã³ã
ããããŒã« 300mlã®ãã·ã¬ã³äž460ïœã®ã·ã¹âïŒã»ïŒâãž
ã¡ãã«ãããªãžã³ã®æ¹æ溶液ã278ïœã®ïŒâã
ãã¢ãããããŒã«ãšå ±ã«15åéã«ããã€ãŠåŠç
ããããã®æ··åç©ãïŒæéæ¹æå ç±éæµãã次
ãã§16æéæ¹æãã€ã€å·åŽããããããã®æ··å
ç©ãéãããããŠæ¶²ãæžå§äžã«èžçºãã
ãããã®æ®æž£ãæžå§äžã«èžæºãããšã·ã¹âïŒã»
ïŒâãžã¡ãã«âïŒâãããªãžã³ãããããŒã«
ïŒb.p.147ã149âïŒ25mmïŒãåŸãããã äŸ ïŒ ã«ãã»ã«åŠæ¹ç©ã次ã®ããã«ããŠèª¿è£œãããã
ïŒSwissïŒCF1ç³»ããŠã¹ïŒäœé21ã29ïœãçŽïŒé±
什ïŒã®éããã³éãçšããŠãã®æ¥æ§æ¯æ§ã調ã¹ã
çµæã¯ä»¥äžã®ãšããã§ãã€ããè©Šéšã«çšãããã
ã®ã¯æ¬çºæã«ããååç©ã®å¡©é žå¡©ã§ããã é é LD50ïŒmgïŒKgïŒïŒéèå æäžïŒ 24.07 24.42 æŽã«ãæ¬çºæã¯ïŒïŒãâïŒâã·ã¹âαâãïŒâ
ïŒïŒã»ïŒâãžã¡ãã«âïŒâãããªãžãã«ïŒããã
ã«ãâαâããšãã«âïŒâããªãžã³ã¡ã¿ããŒã«ã
ãã³ãã®è¬ç©åŠçã«èš±å®¹ãããé žä»å å¡©ãå å«ã
ãå»è¬çµæç©ã«ãé¢ãããè¬ç©åŠçã«èš±å®¹ããã
é žä»å 塩圢æ ã®ãã®ã®ããã€ãã®å žåäŸã¯ãå¡©é ž
å¡©ãç¡«é žå¡©ãçé žå¡©ãã¯ãšã³é žå¡©ããã¢ã³é žå¡©ã
é ¢é žå¡©ããã³ãã¬ã€ã³é žå¡©ã§ããã æŽã«è©³ããã¯ãïŒïŒãâïŒâã·ã¹âαâãïŒâ
ïŒïŒã»ïŒâãžã¡ãã«âïŒâãããªãžãã«ïŒããã
ã«ãâαâããšãã«âïŒâããªãžã³ã¡ã¿ããŒã«ã
ãã³ãã®è¬ç©åŠçã«èš±å®¹ãããé žä»å å¡©ã¯ãïŒæ¥
äœéïŒKgåœãçŽ0.1mgãçŽ10mgã®ç¯å²ã®éã§æäž
ããå Žåãåºä¹³é¡äŸãã°ç«ãç¬ã銬ã人ãã®ä»ã®
å¿èäžæŽèã®å¶åŸ¡ã«é«åºŠã«æçšã§ããããããŠã
ã®ãããªè¬éåäœã䜿çšããã°äœéçŽ70Kgã®åäœ
ã«å¯ŸããŠã¯åèšã§çŽïŒmgãçŽ700mgã®æŽ»æ§æåã
24æéã®éã«å¥œãŸããã¯åå²ããŠæäžãããããš
ã«ãªãã奜ãŸããè¬éæäžæ³ã¯ãïŒæ¥åœãäœéïŒ
KgåœãïŒmgãïŒmgç¯å²ã®æŽ»æ§æåã䜿çšãããã
ã®å Žåãå šïŒæ¥éè¬éãïŒåäœã«åå²ãããããŠ
ãããé©åœãªæéééåŸã«æåããã®ã§ããã æ¬çºæã®ååç©ã¯ãä»»æã®äŸ¿å®ãªçµè·¯ã§ãäŸã
ã°çµå£çã«ãè ¹è å çã«ãç®äžã«ãçèå ãŸãã¯
éèå çã«æäžããããšãã§ããã æŸæããå®å®æ§ããã³éçµè žçšã«ææãããé©
å¿æ§ãæããæ¬çºæã®çµæç©ã¯ãããã¯ã«äŸãã°
æ°Žãå€äŸ¡èèªæã¢ã«ã³ãŒã«ãŸãã¯ãããã®æ··åç©
äžã«0.10ïŒ ã10.0ééïŒ ã®æŽ»æ§ååç©ã溶解ãã
ãããšã«ãã€ãŠåŸããããæ°Žã®ä»ã«ãç¹ã«æºè¶³ã
ã¹ããã®ã¯ã°ãªã»ãªã³ããããã¬ã³ã°ãªã³ãŒã«ã
ãã³ããªãšãã¬ã³ã°ãªã³ãŒã«ã§ãããããªãšãã¬
ã³ã°ãªã³ãŒã«ã¯ãæ°Žããã³ææ©æ¶²äœäž¡è ã«å¯æº¶æ§
ã§ãããŠçŽ200ãçŽ1500ã®ååéãæããäžæ®çº
æ§ã®åžžæ ã§æ¶²äœç¶ã®ããªãšãã¬ã³ã°ãªã³ãŒã«ã®æ··
åç©ãããªãã åèšããã¯ã«ã«æº¶è§£ãããããã掻æ§ååç©ã®
éã¯0.10ã20.0ééïŒ ã«å€åããããããã©ãã
䜿çšããã掻æ§ååç©éã¯çŽ1.0ãçŽ10.0ééïŒ
ã§ããããšã奜ãŸãããåèšã®äžæ®çºæ§ããªãšã
ã¬ã³ã°ãªã³ãŒã«ã®çš®ã ã®æ··åç©ã䜿çšããããã
ã©ããçŽ200ãçŽ400ã®å¹³åååéãæããæ··åç©
ã®äœ¿çšã奜ãŸããã åèšååç©ã®ä»ã«ãæ¬çºæã®éçµè žæäžçšæº¶æ¶²
ã«ã¯ããŸã现èããã³ãã³ã®æ±æãé²æ¢ãããã
ã«äœ¿çšãããçš®ã ã®ä¿åå€ãå«æãããããšãã§
ããããã®ãããªç®çã«äœ¿çšãããä¿åå€ã¯ãäŸ
ãã°ãã³ãžã«ã¢ã«ã³ãŒã«ãããªã¹ãã«âγâãã³
ãªããŠã ã¯ããªããããšãã«ç¡é žæ°Žéããã³ã¶ã«
ã³ããŠã ã¯ããªããããšããã«ã¢ã«ã³ãŒã«ãïœâ
ã¯ããããšãã«âαâã°ãªã»ããŒã«ãšãŒãã«ãã¡
ãã«ããã³ãããã©ãã³ããã³ãã¡ããµãŒã«ã§ã
ããå®éåé¡ãšããŠé žåé²æ¢å€ã䜿çšããããšã
䟿å©ã§ãããé©åœãªé žåé²æ¢å€ãšããŠã¯ãäŸãã°
éäºç¡«é žãããªãŠã ãã¡ã¿éäºç¡«é žãããªãŠã ã
ããã³ãããªãŠã ãã«ã ã¢ã«ãããã¹ã«ããã·ã¬
ãŒããããããããäžè¬ã«ã¯ãçŽ0.05ãçŽ0.2ïŒ
æ¿åºŠã®é žåé²æ¢å€ã䜿çšãããã 掻æ§ååç©ã®å¥œãŸããæ¿åºŠã¯ããã®çµæç©ãæ
å³ãããŠããç®çãçè泚å°ã§ããå Žåã«ã¯ãæ
çµçµæç©ã®ïŒã50mgïŒmlã§ããããããã¯é©åœé
ã®æ°ŽãŸãã¯éèå æ²»ççšã«äœ¿çšãããåžé液äŸã
ã°ç匵ã°ã«ã³ãŒã¹ã§åžéããå Žåã«ã¯ãéèå é©
çšã«ãçããé©å¿ãããããã®äœ¿çšã«å¯ŸããŠã¯ã
çŽ0.5ã25mgïŒmlãŸã§äžãã掻æ§ååç©åææ¿åºŠ
ãæºè¶³ãã¹ããã®ã§ããããããã¯ãŸãã飲çšæ°Ž
ã§åžéããå Žåã«ã¯çµå£æäžçšã«ãé©çšãããã æ¬çºæã®æŽ»æ§ååç©ã¯äŸãã°äžæŽ»æ§åžé液ãŸã
ã¯ååå¯èœãªé£çšæ äœã䜿çšããŠçµå£çã«æäžã
ãããšãã§ãããããŸãã¯ãããã¯ç¡¬è³ªãŸãã¯è»
質ãŒã©ãã³ã«ãã»ã«äžã«å°å ¥ããããšãã§ããã
ãŸãã¯ããããå§çž®æ圢ããŠé å€ãšããããšãã§
ããããŸãã¯ããããçŽæ¥é£é€çšé£åãšæ··åãã
ããšãã§ãããçµå£çæ²»ççšæäžã«å¯ŸããŠã¯ãæ¬
çºæã®æŽ»æ§ååç©ã賊圢å€ã«æ··å ¥ãããããŠé
å€ããããŒããã«ãã»ã«ããšãªãã·ã«ãæžæ¿å€ã
ã·ãããããŠãšãŒãã¢ãŒãããŠãŒã€ã³ã°ã¬ã ãã®
ä»ã®åœ¢ã§äœ¿çšããããšãã§ããããã®ãããªçµæ
ç©ããã³è£œå€ã¯å°ããšã0.1ïŒ ã®æŽ»æ§ååç©ãå«
æããŠããã¹ãã§ãããçµæç©ããã³è£œå€äžã®ïŒ
ã¯å¿è«å€åãããããšãã§ãããããŠããã¯äŸ¿å©
ã«ã¯åäœééã®çŽïŒãçŽ75ïŒ ãŸãã¯ãã以äžã§ã
ãããã®ãããªæ²»ççã«æçšãªçµæç©ãŸãã¯è£œå€
äžã®æŽ»æ§ååç©ã®éã¯ãé©åœãªè¬éãåŸãããã
ããªãã®ã§ãããæ¬çºæã®å¥œãŸããçµæç©ãŸãã¯
補å€ã¯ãçµå£è¬éåäœåœ¢æ ãçŽïŒã200mgã®æŽ»æ§
ååç©ãå«æããããã«è£œé ãããã ãã®é å€ããããŒãããã«ãã«ãã»ã«ãã®ä»ã«
ã¯ã次ã®ãã®ããå«æãããããšãã§ãããçµå
å€äŸãã°ãã©ã¬ã«ã³ããŽã ãã¢ã«ã·ã¢ãŽã ãã³ãŒ
ã³ã¹ã¿ãŒããŸãã¯ãŒã©ãã³ã賊圢å€äŸãã°çé žãž
ã«ã«ã·ãŠã ã厩å£å€äŸãã°ã³ãŒã³ã¹ã¿ãŒãã銬éŽ
è¯æŸ±ç²ãã¢ã«ã®ã³é žãã®ä»ãæ»å€äŸãã°ã¹ãã¢ãª
ã³é žãã°ãã·ãŠã ãããã³çå³æäŸãã°èç³ãä¹³
ç³ãŸãã¯ãµãã«ãªã³ãŸãã¯è³éŠå€äŸãã°ãããŒã
ã³ããå¬ç·æ²¹ãŸãã¯ããšãªãŒéŠæã§ãããè¬éå
äœåœ¢æ ãã«ãã»ã«ã®å Žåã«ã¯ãããã¯åèšã®ãã
ãªçš®é¡ã®ç©è³ªã®ä»ã«æ¶²äœæ äœäŸãã°èèªæ²¹ãå«æ
ããããšãã§ãããçš®ã ã®ãã®ä»ã®ç©è³ªãäŸãã°
ã³ãŒãã€ã³ã°ãšããŠååšãããããšãã§ãããã
ããã¯ãè¬éåäœã®ç©çç圢ç¶ããã以å€ã®æ§åŒ
ã§ä¿®æ£ããããã«é å€ããã«ãŸãã¯ã«ãã»ã«ãã·
ãšã©ãã¯ãç ç³ãŸãã¯ããã¹ã§ã³ãŒãã€ã³ã°ãã
ããšãã§ãããã·ããããŸãã¯ãšãªãã·ã«ã«ã¯ã
掻æ§ååç©ãçå³å€ãšããŠã®èç³ãä¿åæãšããŠ
ã®ã¡ãã«ããã³ãããã«ãã©ãã³ãææããã³è³
éŠæäŸãã°ããšãªãŒãŸãã¯ãªã¬ã³ãžéŠæãå«æã
ããããšãã§ãããå¿è«ããã¹ãŠã®è¬éåäœåœ¢æ
ã®è£œé ã«äœ¿çšããããã¹ãŠã®ç©è³ªã¯ãè¬ç©åŠçã«
çŽç²ã§äžã€äœ¿çšãããéã«ãããŠå®è³ªçã«ç¡æ¯æ§
ã§ããã¹ãã§ããã æ¬çºæã次ã®å®æœäŸã«ãã説æããã äŸ ïŒ 200mlã®ããã©ããããã©ã³äžã«ãæ¹æãã€ã€
â78âã§180mlã®ããã¿ã³äžã®1.6Mããã«ãªããŠ
ã 溶液ãå ããããã®æ··åç©ãçªçŽ äžã«æ¹æãã
ãããã®éã«50mlã®ããã©ããããã©ã³äž43ïœã®
ïŒâããã¢ããªãžã³æº¶æ¶²ãåŸåŸã«ãã®æž©åºŠãâ65
â以äžã«ä¿ã¡ã€ã€å ãããïŒæéæ¹æåŸããã®æ··
åç©ã10åéã«ããã€ãŠ70mlã®ããã©ããããã©
ã³äž65ïœã®ã·ã¹âγâïŒïŒã»ïŒâãžã¡ãã«ãããª
ãžãïŒãããããšãã³ã®æº¶æ¶²ã§åŠçãããããŠâ
65ãâ75âã§æŽã«ïŒæéæ¹æããããã®æ··åç©ã
æ¹æããããŠïŒæéã«ããã€ãŠïŒâãŸã§å æž©ãã
ãã次ãã§30mlã®æ°Žã§åŠçãããäžæŸã¿ã®æ©è²å±€
ãæ²æŸ±ããåºäœããåŸçãããããŠæžå§äžã«ãã®
åã®äœç©ã®çŽ1/3ãŸã§èžçºãããããã®æ®æž£ã2.5
ã®å·åžæ°Žæ§é žåãããªãŠã äžã«æ³šããåŸããã
ïŒïŒãâïŒâã·ã¹âαâãïŒâïŒïŒã»ïŒâãžã¡ãã«â
ïŒâãããªãžãã«ïŒãããã«ãâαâããšãã«â
ïŒâããªãžã³ã¡ã¿ããŒã«ã®æ²æŸ±ãéã«ããé€å»
ããæ°ŽæŽããããŠä¹Ÿç¥ããããç³æ²¹ãšãŒãã«ãã
çµæ¶ååŸã®èç¹70ã71âã ãã®çæç©ãæ°Žæ§ã¡ã¿ããŒã«ããåçµæ¶ããã
å Žåäžæ°Žåç©ãåŸããããm.p.101ã102âã ã¢ãå¡©åæ°ŽçŽ é žå¡©ã¯ãïŒâãããããŒã«äžã«ç¡
æ°Žéé¢å¡©åºã溶解ããããããŠïŒâãããããŒã«
äžã®10ïŒ ã®ä¹Ÿç¥å¡©åæ°ŽçŽ æº¶æ¶²ã®åœéãå ãã次ã
ã§ãšãŒãã«ã§åžéããããŠæ²æŸ±ããå¡©ãéãã
ããšã«ãã€ãŠè£œé ããããm.p.171ã172âã äžéäœã®è£œé ã¯æ¬¡ã®ããã«ããŠãªãããã (a) ã·ã¹âγâïŒïŒã»ïŒâãžã¡ãã«ãããªãžãïŒ
ãããããšã㳠γâã¯ãããããããšãã³ãšãã¬ã³ã±ã¿ãŒã«
619ïœãã·ã¹âïŒã»ïŒâãžã¡ãã«ãããªãžã³700
ïœããã³16ïœã®æ²åãããªãŠã ã®æ··åç©ã48æ
éæ¹æãã€ã€éæµå ç±ããããã®æ··åç©ãå·åŽ
ããïŒã®ç¡æ°ŽãšãŒãã«ã§åžéããããŠéã
ãŠã·ã¹âïŒã»ïŒâãžã¡ãã«ãããªãžã³å¡©é žå¡©ã
é€å»ããããã®ãã€ã«ã¿ãŒã±ãŒããïŒã®ãšãŒ
ãã«ã§æŽããããŠæ¶²ããã³æŽæ¶²ãåãããåŸ
ããããšãŒãã«æº¶æ¶²ãïŒåã500mlåºåéã®æ°Ž
ã§æŽãã次ãã§ïŒã®æ°Žäž300mlã®æ¿å¡©é žã®æº¶
液ã§æœåºããããã®é žæœåºæ¶²ã500mlã®ãšãŒã
ã«ã§æŽãã次ãã§70ã80âã«å ç±ãããããŠæ¬¡
ãã§16æéãããŠå®€æž©ãŸã§å·åŽããããåŸãã
ã溶液ã50ïŒ æ°Žæ§æ°Žé žåãããªãŠã ã§å¡©åºæ§ãš
ãããããŠææ©å±€ãåé¢ããããã®æ°Žæ§å±€ã
500mlã®ãšãŒãã«ã§æœåºãããããŠãã®æœåºæ¶²
ãææ©å±€ã«åãããåããæœåºæ¶²ãæ°Žã§æ°åæŽ
ãã也ç¥ããããããŠèžçºãããããã®æ²¹æ§æ®
枣ãæžå§äžã«èžæºããŠã·ã¹âγâïŒïŒã»ïŒâãž
ã¡ãã«ãããªãžãïŒãããããšãã³ïŒb.p.138
ã141âïŒ0.1mmïŒãåŸãã (b) γâã¯ãããããããšãã³ãšãã¬ã³ã±ã¿ãŒã« 500ïœã®Î³âã¯ãããããããšãã³ã225ïœã®
ãšãã¬ã³ã°ãªã³ãŒã«ã10ïœã®ïœâãã«ãšã³ã¹ã«
ãã³é žããã³1.5ã®ãã³ãŒã³ã®æ··åç©ãæ°Žã
åé¢ãã€ã€æ°ŽåéããããŸã§éæµäžã«å ç±ã
ããåŸããã溶液ãå·åŽãã10mlã®ããªãšãã«
ã¢ãã³ã§äžåããããŠæžå§äžã«èžçºããããšã
ã以äžç²Ÿè£œããããšãªãã«äœ¿çšã«é©åœãªÎ³âã¯
ãããããããšãã³ãšãã¬ã³ã±ã¿ãŒã«ãåŸãã
ãããã®ãã®ã®çŽç²ãªç©è³ªã¯100ã118âïŒ0.1
ã0.8mmã§æ²žéš°ããããŠ57ã59âã§æº¶èããã äŸ ïŒ 50mlã®ããã©ããããã©ã³äž18.98ã®ã·ã¹âïŒ
âïŒïŒâã¯ãããããã«ïŒâïŒã»ïŒâãžã¡ãã«ãã
ãªãžã³ã®æº¶æ¶²ãçªçŽ é°å²æ°äžã«1.4ïœã®ãªããŠã
ã¯ã€ã¢ãš50mlã®ããã©ããããã©ã³ãšã®æ¹ææ··å
ç©äžã«ïŒæéãããŠæ»Žå ãããæ·»å å®äºåŸããã®
æ··åç©ãçªçŽ äžã«æŽã«ïŒæéæ¹æããéå°ã®ãªã
ãŠã éå±ãæäœæ¥ã§é€å»ãããããŠ100mlã®ãã
ã©ããããã©ã³äž18.3ïœã®ïŒâãã³ãŸã€ã«ããªãž
ã³ã®æº¶æ¶²ãæ¹æãã€ã€ïŒæéãããŠæ»Žå ãããã
ã®æ··åç©ã16æéæ¹æãã次ãã§ïŒmlã®æ°Žã§åŠç
ããããã®ææ©çžãæ²æŸ±ããåºäœããåŸçããã
ããŠæžå§äžã«ãã®æåã®äœç©ã®çŽ1/4ãŸã§èžçºã
ããããã®æº¶æ¶²ã400mlã®æ°Žäžã«æ³šãããã®æº¶æ¶²
ãé ¢é žã§é žæ§ãšãããããŠãšãŒãã«ã§æŽãããã®
æ°Žæ§é žæº¶æ¶²ãæ°Žæ§æ°Žé žåãããªãŠã ã§å¡©åºæ§ãšã
ãããŠãšãŒãã«ã§æœåºããããšãŒãã«æœåºæ¶²ãæ°Ž
æŽãã也ç¥ããããŠèžçºããããšãïŒïŒãâïŒâã·
ã¹âαâãïŒâïŒïŒã»ïŒâãžã¡ãã«âïŒâãããªãž
ãã«ïŒãããã«ãâαâããšãã«âïŒâããªãžã³
ã¡ã¿ããŒã«ãåŸãããããã®ãã®ã¯æ°Žæ§ã¡ã¿ããŒ
ã«ããçµæ¶ååŸm.p.100ã102âïŒäžæ°Žåç©ïŒã
åŸãããã äžéäœã®è£œé ã¯æ¬¡ã®ãšããã§ããã (a) ã·ã¹âïŒâïŒïŒâã¯ãããããã«ïŒâïŒã»ïŒâ
ãžã¡ãã«ãããªãžã³ 400mlã®ãã³ãŒã³äž171ïœã®ã·ã¹âïŒã»ïŒâãž
ã¡ãã«âïŒâãããªãžã³ãããããŒã«ã®æ¹æ溶
液ãïŒãïŒãã«å·åŽãããããŠããªãã«ã¯ããª
ã143ïœã30åéãããŠæ»Žå ããããã®æ··åç©
ã次ãã§ïŒæéå ç±éæµããå·åŽããããŠïŒ
ã®ãšãŒãã«ã§åžéãããåŸãããã·ã¹âïŒâ
ïŒïŒâã¯ãããããã«ïŒâïŒã»ïŒâãžã¡ãã«ãã
ãªãžã³å¡©é žå¡©ã®æ²æŸ±ãéã«ããéãããïŒâ
ãããããŒã«ãšãŒãã«ããçµæ¶ååŸã®èç¹ã¯
173ã174âã§ãããéé¢å¡©åºã¯å¿ èŠã«å¿ããŠæ
å°éã®æ°Žã«ãã®å¡©é žå¡©ã溶解ãããå·åŽããã
ãŠå°éå°ã®50ïŒ æ°Žæ§æ°Žé žåãããªãŠã ãå ãã
ããšã«ãã補é ããããéé¢ããå¡©åºãçŽã¡ã«
æ°åºåéã®ãã³ãŒã³ã§æœåºããããã®æœåºæ¶²ã
åãã也ç¥ãããããŠèžçºããããšéé¢å¡©åºã§
ããã·ã¹âïŒâïŒïŒâã¯ãããããã«ïŒâïŒã»ïŒ
âãžã¡ãã«ãããªãžã³ãåŸãããã (b) ã·ã¹âïŒã»ïŒâãžã¡ãã«âïŒâãããªãžã³ã
ããããŒã« 300mlã®ãã·ã¬ã³äž460ïœã®ã·ã¹âïŒã»ïŒâãž
ã¡ãã«ãããªãžã³ã®æ¹æ溶液ã278ïœã®ïŒâã
ãã¢ãããããŒã«ãšå ±ã«15åéã«ããã€ãŠåŠç
ããããã®æ··åç©ãïŒæéæ¹æå ç±éæµãã次
ãã§16æéæ¹æãã€ã€å·åŽããããããã®æ··å
ç©ãéãããããŠæ¶²ãæžå§äžã«èžçºãã
ãããã®æ®æž£ãæžå§äžã«èžæºãããšã·ã¹âïŒã»
ïŒâãžã¡ãã«âïŒâãããªãžã³ãããããŒã«
ïŒb.p.147ã149âïŒ25mmïŒãåŸãããã äŸ ïŒ ã«ãã»ã«åŠæ¹ç©ã次ã®ããã«ããŠèª¿è£œãããã
ãè¡šã
掻æ§æåã柱ç²ããã³ã¹ãã¢ãªã³é
žãã°ãã·ãŠ
ã ãäžç·ã«æ··åããããã®æ··åç©ãé©åœãªãµã€ãº
ã®ç¡¬è³ªã·ãšã«ã«ãã»ã«ãåã«ãã»ã«åœã285mgã®
å å¡«ééã§æºããã
ã ãäžç·ã«æ··åããããã®æ··åç©ãé©åœãªãµã€ãº
ã®ç¡¬è³ªã·ãšã«ã«ãã»ã«ãåã«ãã»ã«åœã285mgã®
å å¡«ééã§æºããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ ïŒïŒãâïŒâã·ã¹âαâãïŒâïŒïŒã»ïŒâãžã¡ã
ã«âïŒâãããªãžãã«ïŒãããã«ãâαâããšã
ã«âïŒâããªãžã³ã¡ã¿ããŒã«ããã³ãã®é žä»å
å¡©ã ïŒ ïŒïŒãâïŒâã·ã¹âαâãïŒâïŒïŒã»ïŒâãžã¡ã
ã«âïŒâãããªãžãã«ïŒãããã«ãâαâããšã
ã«âïŒâããªãžã³ã¡ã¿ããŒã«å¡©é žå¡©ã§ãããåèš
第ïŒé èšèŒã®ååç©ã ïŒ ããªãžã«ãªããŠã ãã·ã¹é äœãæããåŒ ã®ååç©ãšåå¿ãããçæããäžéäœãå æ°Žå解
ããããŠçæç©ãéé¢å¡©åºãšããŠããŸãã¯é žä»å
å¡©ãšããŠåé¢ããããšãå å«ããã ïŒïŒãâïŒâã·ã¹âαâãïŒâïŒïŒã»ïŒâãžã¡ãã«
âïŒâãããªãžãã«ïŒãããã«ãâαâããšãšã«
âïŒâããªãžã³ã¡ã¿ããŒã«ããã³ãã®é žä»å å¡©ã®
補é æ³ã ïŒ ã·ã¹é äœãæããåŒ ã®ååç©ãïŒâãã³ãŸã€ã«ããªãžã³ãšåå¿ããã
çæããäžéäœãå æ°Žå解ããããŠãã®çæç©ã
éé¢å¡©åºãŸãã¯é žä»å å¡©ãšããŠåé¢ããããšãå
å«ãããïŒïŒãâïŒâã·ã¹âαâãïŒâïŒïŒã»ïŒâãž
ã¡ãã«âïŒâãããªãžãã«ïŒãããã«ãâαâã
ãšãã«âïŒâããªãžã³ã¡ã¿ããŒã«ããã³ãã®é žä»
å å¡©ã®è£œé æ³ã ïŒ å»è¬çšæ äœãšïŒïŒãâïŒâã·ã¹âαâãïŒâ
ïŒïŒã»ïŒâãžã¡ãã«âïŒâãããªãžãã«ïŒããã
ã«ãâαâããšãã«âïŒâããªãžã³ã¡ã¿ããŒã«ãŸ
ãã¯ãã®è¬ç©åŠçã«èš±å®¹ãããé žä»å å¡©ãšãå å«
ããŠããè¬éåäœåœ¢æ ã®æäžæŽèçµæç©ã ïŒ è¬éåäœåœãïŒã200mgã®æŽ»æ§æåãæããŠ
ãããåèšç¬¬ïŒé èšèŒã®çµæç©ã
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/772,203 US4112103A (en) | 1976-04-15 | 1977-02-25 | Antiarrhythmic (+,-)-cis-α-[3-(2,6-dimethyl-1-piperidinyl)propyl]-α-phenyl-2-pyridinemethanols |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS53105479A JPS53105479A (en) | 1978-09-13 |
JPS6257632B2 true JPS6257632B2 (ja) | 1987-12-02 |
Family
ID=25094280
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1665978A Granted JPS53105479A (en) | 1977-02-25 | 1978-02-17 | Novel pyridinemethanol compound and method for its production |
Country Status (11)
Country | Link |
---|---|
JP (1) | JPS53105479A (ja) |
AT (1) | AT358040B (ja) |
BE (1) | BE864033A (ja) |
CA (1) | CA1096382A (ja) |
CH (1) | CH635095A5 (ja) |
DE (1) | DE2806654A1 (ja) |
DK (1) | DK143229C (ja) |
ES (1) | ES467100A1 (ja) |
FR (1) | FR2381761A1 (ja) |
GB (1) | GB1581096A (ja) |
PH (1) | PH13125A (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2818914B2 (ja) * | 1991-04-05 | 1998-10-30 | ã·ã£ãŒãæ ªåŒäŒç€Ÿ | å€ç®çã¹ããŒã çºçåš |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE757408A (fr) * | 1969-10-13 | 1971-04-13 | Thomae Gmbh Dr K | Nouveaux butanols tertiaires a constituants basiques |
-
1978
- 1978-02-16 BE BE185237A patent/BE864033A/xx not_active IP Right Cessation
- 1978-02-16 DE DE19782806654 patent/DE2806654A1/de active Granted
- 1978-02-17 ES ES467100A patent/ES467100A1/es not_active Expired
- 1978-02-17 CH CH177978A patent/CH635095A5/de unknown
- 1978-02-17 CA CA297,176A patent/CA1096382A/en not_active Expired
- 1978-02-17 JP JP1665978A patent/JPS53105479A/ja active Granted
- 1978-02-17 AT AT117078A patent/AT358040B/de not_active IP Right Cessation
- 1978-02-17 PH PH20795A patent/PH13125A/en unknown
- 1978-02-17 FR FR7804568A patent/FR2381761A1/fr active Granted
- 1978-02-17 DK DK73278A patent/DK143229C/da not_active IP Right Cessation
- 1978-02-17 GB GB6493/78A patent/GB1581096A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
CA1096382A (en) | 1981-02-24 |
DK73278A (da) | 1978-08-26 |
DE2806654A1 (de) | 1978-08-31 |
CH635095A5 (en) | 1983-03-15 |
AT358040B (de) | 1980-08-11 |
FR2381761B1 (ja) | 1982-03-26 |
BE864033A (fr) | 1978-06-16 |
PH13125A (en) | 1979-12-12 |
DK143229C (da) | 1981-11-30 |
DE2806654C2 (ja) | 1987-07-16 |
JPS53105479A (en) | 1978-09-13 |
ATA117078A (de) | 1980-01-15 |
ES467100A1 (es) | 1978-11-01 |
GB1581096A (en) | 1980-12-10 |
FR2381761A1 (fr) | 1978-09-22 |
DK143229B (da) | 1981-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU187868B (en) | Process for producing dihydropyridine derivatives | |
EP0378207A1 (en) | Cyclic amine compounds and their use | |
US4097481A (en) | Tertiary amide derivatives of pyrrolidine and piperidine | |
FI106797B (fi) | MenetelmÀ atsabisyklo [2.2.1] heptan-3-onioksiimien valmistamiseksi | |
KR840001836B1 (ko) | 9-ìë¯žë žìí¬í룚ì€ë ì ì ì¡°ë°©ë² | |
GB2114565A (en) | Amino carboxylic acids and derivatives thereof | |
AU599954B2 (en) | 3-alkoxy-2-aminopropylamines useful as cardiovascular agents | |
US3479346A (en) | N-acyl-n- (and n,n-bis-) ((1-piperidyl)-lower-alkyl)amines | |
JPH05213751A (ja) | äžé£ã®ã¢ã¬ã³ãã³ããã³ã€ãœã¢ã¬ã³ãã³ã®ãã³ãã³æ§æŽ»æ§ | |
JP3053418B2 (ja) | æ°èŠã®çœ®æã¢ã«ãã«ãããªãžã³ãšã³ã¬ã¹ãããŒã«åæé»å®³å€ãšããŠã®ãã®çšé | |
US4028366A (en) | 2-Naphthyl-lower-alkanoylamines | |
EP0230020B1 (en) | 1,2,3,4,4a,9b-hexahydro-4a-aminoalkyldibenzofurans, a process for their preparation and their use as medicaments | |
EP0389425B1 (de) | Neue Benzothiopyranylamine | |
US4758577A (en) | 4-(5H-dibenzo[a,d]cyclohepten-5-yl)piperidine compounds for treating cardiovascular disorders | |
US3926988A (en) | Substituted pyrazoles | |
JPS6257632B2 (ja) | ||
US4112103A (en) | Antiarrhythmic (+,-)-cis-α-[3-(2,6-dimethyl-1-piperidinyl)propyl]-α-phenyl-2-pyridinemethanols | |
US3228984A (en) | 1, 4-bis-cyclic and aryl-amino-[2.2.2] bicyclooctane derivatives | |
KR900000565B1 (ko) | ë¶ìíŽìì ë° ì°ìžìŠ ì¹ë£ì ë¡ìì ê°êµë ë¹ì¬ìŽíŽëŠ ìŽë¯žë | |
CH619923A5 (en) | Process for the preparation of phenylalkylamines | |
US4758563A (en) | 3-alkoxy-2-aminopropyamines, cardiovascular compositions and use | |
US4008276A (en) | Phenyl-lower-alkylamines | |
KR840000103B1 (ko) | 1, 1'-ë¹íë-2-ìŒ ìí¬ì믌 ì ë첎ì ì ì¡°ë°©ë² | |
US4333930A (en) | Orthoarylideneaminophenethylamines and pharmaceutical compositions | |
JPH0764843B2 (ja) | æ°èŠååç©ïŒãã®è£œæ³åã³ãããå«ãå»è¬çµæç© |